Phase
Condition
Thromboembolism
Venous Thromboembolism
Venous Thrombosis
Treatment
N/AClinical Study ID
Ages 18-49 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Non-pregnant women, age <50,
Objectively diagnosed VTE or atrial fibrillation within the previous 30 days, and nomenstrual cycle since diagnosis
Patient reported active menstruation, requiring >3 menstrual periods in the previous 6 months
Clinical plan and patient agreement to treat with oral anticoagulation for 3 monthsor longer
Patients must have a working mobile phone
Exclusion
Exclusion Criteria:
Package insert exclusions for Eliquis or Xarelto: [active pathological bleeding orsevere hypersensitivity reaction to XARELTO or ELIQUIS (e.g., anaphylacticreactions)]
Plan to become pregnant in the next three months.
Concomitant prescribed use of aspirin or thienopyridines or other platelet inhibitingdrugs
Plan for surgical hysterectomy or endometrial ablation
Known uterine cancer
Von Willebrand's disease, or hemophilia
Known coagulopathy from liver disease
Conditions likely to preclude adherence to study procedures: Active intravenous druguse, known alcoholism, homelessness, or uncontrolled psychiatric illness.